Clincosm LogoSign in Get a demo

Recovery Management Intervention in China

Sponsor
University of California, Los Angeles (Other)
Overall Status
Completed
CT.gov ID
NCT01270100
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
1
Location
1
Arm

Study Details

Study Description

Brief Summary

The purpose of the study is to develop and pilot-test a Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China.

The project has the following specific aims:
Primary aims:

Aim 1. To engage key stakeholders in the local communities involved in supporting the transition of heroin addicts released from compulsory rehabilitation to the community; Aim 2. To identify potential barriers for participating in MMT in China; Aim 3. To develop and deliver educational/training materials on HIV risks, relapse prevention, and MMT; Aim 4. To adapt and develop the Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China; Aim 5. To conduct a pilot trial and obtain preliminary outcome data associated with RMI, relative to enhanced standard care.

Secondary aim:

Aim 6. To explore predictors of relapse and HIV/AIDS risk behaviors.

It is hypothesized that the intervention will reduce drug use relapse and the negative consequences associated with relapse, including HIV risk behaviors

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Recovery management
 N/A

Study Design

Study Type:
Interventional
Official Title:
Reducing HIV/AIDS and Drug Abuse Among Heroin Addicts Released From Compulsory Rehabilitation in China

Arms and Interventions

Arm Intervention/Treatment
Experimental: Recovery management intervention

Behavioral: Recovery management

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All

    Inclusion Criteria:The study population will be drawn from all adult patients at participating compulsory rehabilitation facilities who:

    1. have been incarcerated for at least one year and would have been eligible for MMT at the time of incarceration,

    2. have at least 1 month remaining before release,

    3. met the DSM-IV criteria for heroin dependence at the time of incarceration,

    4. are willing to enroll in methadone maintenance treatment, and

    5. are Shanghai residents who reside in the areas of Shanghai targeted by the study.

    Exclusion Criteria: Individuals diagnosed with severe mental illness will not be eligible to participate.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Shanghai Mental Health Center Shanghai China

    Sponsors and Collaborators

    • University of California, Los Angeles
    • National Institute on Drug Abuse (NIDA)

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01270100
    Other Study ID Numbers:
    • DA025385
    • 1R21DA025385-01
    First Posted:
    Jan 5, 2011
    Last Update Posted:
    Jan 5, 2011
    Last Verified:
    Dec 1, 2010
    Additional relevant MeSH terms:
    HIV Infections

    Study Results

    No Results Posted as of Jan 5, 2011